CINCINNATI, June 21, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company spanning multiple sectors, today ...

Johnson & Johnson (NYSE:JNJ), on Tuesday, reported a first-quarter 2025 adjusted EPS of $2.77, up 2.2% year over year, beating the consensus of $2.60. The pharmaceutical giant reported sales of $21.89 ...

In today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability. That means turning to assets that can hold up under pressure, especially those ...

Biotech stock Anaptysbio cleared a trendline entry near 50 on Monday. Shares are also in a base with a buy point of 52.47.

The Global Biotech Handbook offers opportunities in the biotech sector by detailing regulatory landscapes, clinical trial procedures, intellectual property issues, and market structures across 70 ...

The macroenvironment in 2025 looks grim as signs of a slowdown in the economy set in. The biotech industry experienced a choppy ride in 2024, and the same is likely in store in 2025. Given the ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. BridgeBio’s recently ...

Several biotech stocks have been showing strong action in the stock market recently, underscored by their place on the IBD 50 elite list of growth stocks. Some biotech exchange traded funds are also ...

BeiGene Ltd. (NASDAQ:ONC) stock is trading lower after the company reported mixed first-quarter 2025 financial results on Wednesday. The Chinese biotech reported adjusted earnings per ADS of $1.22, a ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

FBT selects 30 biotechnology stocks based on sales, sales as a percentage of R&D expenditures, and R&D growth compared to three years ago. The ETF launched 19 years ago and has delivered exceptional ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the ...